Market Movers: SQI Diagnostics Receives Funding from the UHN to Validate One Hour COVID-19 Related Test

This morning Toronto based SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), announced they have been selected by the University Health Network (UHN) to receive funding for the validation and testing of their novel assay, known as Rapid Acute Lung Injury Diagnostic, RALI-Dx. Under the research, they will utilize this previously developed SQI assay to assist clinicians in the triaging of patients with COVID-19. Recently the UHN received a  $1 million grant awarded by the Canadian Institutes of Health Research, which the UHN has earmarked a portion to SQI Diagnostics to validate RALI-Dx .

SQI Diagnostics Investor Presentation

SQI Diagnostics isn’t just a ‘Coronoavirus pop up.’ The cash infusion from the UHN demonstrates the company is chasing a real practical solution to help hospitals fight COVID-19. The company has been developing and commercializing proprietary technologies and products for advanced microarray diagnostics for years prior to this grant. Their proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide high quality data.

Joining the global fight against COVID-19 presents a tremendous opportunity for SQI… Not only is it an opportunity to allow our organization to commercialize an assay we have already developed, but it is also an opportunity to make a positive impact for people around the world.”

Eric Brouwer, PhD, interim CEO of SQI

Since announcing the news the stock doubled:

SQI sees an opportunity to help hospitals with scarcity of critical resources such as ICU beds and ventilator machines by providing the ability to objectively identify who requires admission to intensive care. Hospitals are already facing significant pressure in triaging patients in respiratory distress. RALI-Dx is ideally positioned to fill this need and serve as a tool to manage limited critical resources in this historic time of need.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

At the time of publishing, SQI’s share price has risen over 107.1% to 14.5c.


Information for this briefing was found via Sedar and SQI Diagnostics. The author is currently long SQI Diagnostic common shares and may sell them at anytime. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Goliath Extends Golden Gate Lode 130 Metres With 13.45 g/t Gold Equivalent Over 4.85 Metres

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Related News

Congressional Budget Office Predicts Coronavirus Will Cost US Economy $15.7 Trillion

According to a recent forecast released by the Congressional Budget Office (CBO), the US is...

Tuesday, June 2, 2020, 11:19:27 AM

QE Infinity Aimed at Everything! Fed Announces New Asset Buying Program

This morning the Federal Reserve announced a series of new programs to help the markets...

Monday, March 23, 2020, 10:18:45 AM

Datametrex Awarded Tender To Supply 2,000 COVID-19 Test Kits

Datametrex AI (TSXV: DM) appears to have a sales pipeline in the mining sector. This...

Friday, June 5, 2020, 08:43:21 AM

Nio Sees January Sales Slump Due To Coronavirus

Nio Inc (NYSE: NIO) released its January sales figures this morning, and as a result...

Monday, February 10, 2020, 09:01:41 AM

Deutsche Bank Proposes 5% ‘Privilege’ Tax on Those Choosing to Work From Home

The coronavirus pandemic has caused significant shifts in the typical office environment, as many employees...

Saturday, November 14, 2020, 04:03:00 PM